Detalles de la búsqueda
1.
High-Performance Fluorescent Microspheres Based on Fluorescence Resonance Energy Transfer Mode for Lateral Flow Immunoassays.
Anal Chem
; 95(48): 17860-17867, 2023 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050676
2.
Dose-response relationship in non-pharmacological interventions for individuals with mild cognitive impairment: A systematic review and meta-analysis of randomised controlled trials.
J Clin Nurs
; 31(23-24): 3390-3401, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35098610
3.
A Risk Prediction Model Based on Machine Learning for Cognitive Impairment Among Chinese Community-Dwelling Elderly People With Normal Cognition: Development and Validation Study.
J Med Internet Res
; 23(2): e20298, 2021 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625369
4.
Multi-angles of smoking and mild cognitive impairment: is the association mediated by sleep duration?
Neurol Sci
; 40(5): 1019-1027, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778881
5.
Novel litchi-like Au-Ag nanospheres driven dual-readout lateral flow immunoassay for sensitive detection of pyrimethanil.
Food Chem
; 450: 139380, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640535
6.
Effectiveness and acceptability of non-pharmacological interventions in people with mild cognitive impairment: Overview of systematic reviews and network meta-analysis.
J Affect Disord
; 311: 383-390, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35597472
7.
Sleep, inflammation and cognitive function in middle-aged and older adults: A population-based study.
J Affect Disord
; 284: 120-125, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33592430
8.
Effects of computerised cognitive training on cognitive impairment: a meta-analysis.
J Neurol
; 268(5): 1680-1688, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650255
9.
Neuropsychiatric symptoms as prognostic makers for the elderly with mild cognitive impairment: a meta-analysis.
J Affect Disord
; 271: 185-192, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479315
10.
Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia.
Indian J Hematol Blood Transfus
; 35(3): 507-512, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31388265
Resultados
1 -
10
de 10
1
Próxima >
>>